Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 876 to 900 of 2555

TitleReference numberPublishedLast updated
Atrial fibrillation: diagnosis and managementNG196
Plus Sutures for preventing surgical site infectionHTG586
Laser lithotripsy for difficult-to-treat bile duct stonesHTG584
Percutaneous insertion of a closure device to repair a paravalvular leak around a replaced mitral or aortic valveHTG585
Ravulizumab for treating atypical haemolytic uraemic syndromeTA710
Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitisTA708
Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA709
Patient experience in adult NHS services: improving the experience of care for people using adult NHS servicesCG138
Shared decision makingNG197
SYNE-COV for predicting COVID-19 outcomesMIB264
Nivolumab for previously treated unresectable advanced or recurrent oesophageal cancerTA707
Autism spectrum disorder in adults: diagnosis and managementCG142
Autism spectrum disorder in under 19s: support and managementCG170
Ozanimod for treating relapsing–remitting multiple sclerosisTA706
Atezolizumab monotherapy for untreated advanced non-small-cell lung cancerTA705
WoundExpress to manage lower leg woundsMIB261
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex-vivo lung perfusion) for transplantHTG580
Transvaginal laser therapy for stress urinary incontinenceHTG581
Transvaginal laser therapy for urogenital atrophyHTG582
Electrohydraulic lithotripsy for difficult-to-treat bile duct stonesHTG583
Ibrutinib with obinutuzumab for untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (terminated appraisal)TA702
Ibrutinib with rituximab for untreated chronic lymphocytic leukaemia (terminated appraisal)TA703
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapiesTA704
Heavy menstrual bleeding: assessment and managementNG88
Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcersHTG355

Results per page

  1. 10
  2. 25
  3. 50
  4. All